M
Motomi Mori
Researcher at Oregon Health & Science University
Publications - 31
Citations - 3024
Motomi Mori is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 20, co-authored 31 publications receiving 2932 citations. Previous affiliations of Motomi Mori include University of Washington & Sapporo Medical University.
Papers
More filters
Journal ArticleDOI
Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation
Goodrich Jm,Motomi Mori,Gleaves Ca,Du Mond C,Cays M,Ebeling Df,William Buhles,DeArmond B,Joel D. Meyers +8 more
TL;DR: Early treatment with ganciclovir in patients with positive surveillance cultures reduces the incidence of CMV disease and improves survival after allogeneic bone marrow transplantation.
Journal ArticleDOI
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.
Claudio Anasetti,Patrick G. Beatty,Rainer Storb,Paul J. Martin,Motomi Mori,Jean E. Sanders,E. Donnall Thomas,John A. Hansen +7 more
TL;DR: Investigation of the relevance of HLA incompatibility to acute graft-versus-host disease, relapse, and survival in 281 patients with hematologic neoplasms who underwent bone marrow transplantation found it was associated with lower leukemic relapse after transplant in patients with acute lymphocytic leukemia.
Journal ArticleDOI
Etiology and outcome of diarrhea after marrow transplantation: a prospective study.
George J. Cox,Suzanne M. Matsui,Roger S. Lo,Mary S. Hinds,Raleigh A. Bowden,Robert C. Hackman,Walter G. Meyer,Motomi Mori,Phillip I. Tarr,Lyndon S. Oshiro,Juan E. Ludert,Joel D. Meyers,George B. McDonald +12 more
TL;DR: Most cases of diarrhea after marrow transplant are not caused by infection, and clinical signs and symptoms of infection and GVHD were similar, and no clear etiology could be found for self-limited diarrhea.
Journal ArticleDOI
Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.
Scott I. Bearman,Garnet L. Anderson,Motomi Mori,Mary S. Hinds,Howard M. Shulman,George B. McDonald +5 more
TL;DR: The course of VOD after cytoreductive therapy can be predicted by knowing the serum bilirubin and weight gained within 1 to 2 weeks of transplantation, and probability estimates derived from patient data are highly specific and moderately sensitive.
Journal ArticleDOI
Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation.
James M. Goodrich,James M. Goodrich,Elizabeth C. Reed,Motomi Mori,Lloyd D. Fisher,Shawn J. Skerrett,Paula S. Dandliker,Barbara Klis,George W. Counts,Joel D. Meyers +9 more
TL;DR: Among fungemic patients, the number of days of fungemia was a risk factor for tissue invasion while more rapid engraftment was protective, and among infected patients, age, acute graft-versus-host disease, and donor mismatch were factors that increased infection.